Endocrinology, Vol 130, 2505-2512, Copyright © 1992 by Endocrine Society

ARTICLES

Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy

ML Davenport, J Pucilowska, DR Clemmons, R Lundblad, JA Spencer and LE Underwood
Department of Pediatrics, School of Medicine, University of North Carolina, Chapel Hill 27599.

The abundances of insulin-like growth factor binding proteins (IGFBPs) in sera and tissue homogenates of rats at days 12, 15, and 18 of pregnancy were determined by ligand- and immunoblotting. As in serum, IGFBP-3 was abundant in day 12 uterus, placenta, and fetuses, and decreased by day 15. On day 18 of pregnancy, IGFBP-2 was predominant and IGFBP-3 was less than 25% of day 12 values in fetus and placenta, and was undetectable in uterus and decidua. In contrast, IGFBPs in the nonreproductive tissues did not change significantly. IGFBP-3 was more abundant in muscle than heart and liver, and was not detected in lung, kidney, or brain. The decrease in IGFBP-3 in serum and reproductive tissues between days 12 and 15 of pregnancy was temporally related to the appearance of IGFBP-3 protease activity. Proteolytic activity was detectable only at low levels in brain, liver, and spleen, and was undetectable in lung, heart, muscle, and kidney. The specific protease inhibitors that blocked IGFBP-3 proteolytic activities in pregnant rat serum and decidua were virtually identical and suggested inhibition of a divalent cation-dependent tryptic-like serine protease. Furthermore, exposure of bovine IGFBP-3 (in nonpregnant bovine serum) or radiolabeled recombinant human IGFBP-3 to day 18 pregnant rat serum, decidua or uterus resulted in the generation of IGFBP-3 fragments with the same apparent Mrs (29-31 K and 18-23 K). We postulate that tissue- specific degradation may be as important as synthesis in determining IGFBP-3 abundance, and that the dramatic changes in IGFBPs in reproductive and fetal tissues may cause changes in IGF availability which are necessary for rapid tissue growth and differentiation.

This article has been cited by other articles:

				A. Yilmaz, M. E. Davis, and R. C. M. Simmen Estimation of (co)variance components for reproductive traits in Angus beef cattle divergently selected for blood serum IGF-I concentration J Anim Sci, August 1, 2004; 82(8): 2285 - 2292. [Abstract] [Full Text] [PDF]

				L. D. Payet, S. M. Firth, and R. C. Baxter The Role of the Acid-Labile Subunit in Regulating Insulin-Like Growth Factor Transport across Human Umbilical Vein Endothelial Cell Monolayers J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2382 - 2389. [Abstract] [Full Text] [PDF]

				D. C. Martin, J. L. Fowlkes, B. Babic, and R. Khokha Insulin-like Growth Factor II Signaling in Neoplastic Proliferation Is Blocked by Transgenic Expression of the Metalloproteinase Inhibitor TIMP-1 J. Cell Biol., August 23, 1999; 146(4): 881 - 892. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				L. A. Maile, S. Xu, S. C. Cwyfan-Hughes, J. K. Fernihough, J. M. Pell, and J. M. P. Holly Active and Inhibitory Components of the Insulin-Like Growth Factor Binding Protein-3 Protease System in Adult Serum, Interstitial, and Synovial Fluid Endocrinology, December 1, 1998; 139(12): 4772 - 4781. [Abstract] [Full Text] [PDF]

				T. L. Bushman and J. F. Kuemmerle IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta 1 Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1282 - G1290. [Abstract] [Full Text] [PDF]

				M. T. Spicer, B. J. Stoecker, T. Chen, and L. J. Spicer Maternal and Fetal Insulin-Like Growth Factor System and Embryonic Survival During Pregnancy in Rats: Interaction between Dietary Chromium and Diabetes J. Nutr., December 1, 1998; 128(12): 2341 - 2347. [Abstract] [Full Text]

				P. Bang and P. J. Fielder Human Pregnancy Serum Contains at Least Two Distinct Proteolytic Activities with the Ability To Degrade Insulin-Like Growth Factor Binding Protein-3 Endocrinology, September 1, 1997; 138(9): 3912 - 3917. [Abstract] [Full Text] [PDF]

				T. S. Reynolds, K. R. Stevenson, and D. C. Wathes Pregnancy-Specific Alterations in the Expression of the Insulin-Like Growth Factor System during Early Placental Development in the Ewe Endocrinology, March 1, 1997; 138(3): 886 - 897. [Abstract] [Full Text] [PDF]